The Weekly US VAERS Covid Vax Deaths and Adverse Effects By Brian Simpson

The Centers for Disease Control and Prevention (CDC) Vaccine Adverse Event Reporting System (VAERS), is the principal government-funded system for reporting adverse vaccine reactions in the U. S., but is known to vastly under-report vaccine-related deaths and adverse effects by a factor estimated to be 41 to 100.  New data has been released showing a total of 1,103,893 reports of adverse events following COVID vaccines were submitted between December 14, 2020, and February 4, 2022. There was  a total of 23,615 reports of deaths — an increase of 466 over last week — and 188,135 reports of serious injuries, including deaths, during the same  period — up 4,824 compared with the previous week.

 

https://childrenshealthdefense.org/defender/vaers-cdc-child-vaccine-induced-myocarditis-deaths-injuries/?utm_source=salsa&eType=EmailBlastContent&eId=e20315d7-3b00-46f5-a054-4fb3c3f96f32

 

“The Centers for Disease Control and Prevention (CDC) today released new data showing a total of 1,103,893 reports of adverse events following COVID vaccines were submitted between Dec. 14, 2020, and Feb. 4, 2022, to the Vaccine Adverse Event Reporting System (VAERS). VAERS is the primary government-funded system for reporting adverse vaccine reactions in the U.S.

The data included a total of 23,615 reports of deaths — an increase of 466 over the previous week — and 188,135 reports of serious injuries, including deaths, during the same time period — up 4,824 compared with the previous week.

Excluding “foreign reports” to VAERS, 753,482 adverse events, including 10,747 deaths and 70,746 serious injuries, were reported in the U.S. between Dec. 14, 2020, and Feb. 4, 2022.

Foreign reports are reports foreign subsidiaries send to U.S. vaccine manufacturers. Under U.S. Food and Drug Administration (FDA) regulations, if a manufacturer is notified of a foreign case report that describes an event that is both serious and does not appear on the product’s labeling, the manufacturer is required to submit the report to VAERS.

Of the 10,747 U.S. deaths reported as of Feb. 4, 18% occurred within 24 hours of vaccination, 23% occurred within 48 hours of vaccination and 60% occurred in people who experienced an onset of symptoms within 48 hours of being vaccinated.

In the U.S., 541.5 million COVID vaccine doses had been administered as of Feb. 4, including 318 million doses of Pfizer, 205 million doses of Moderna and 18 million doses of Johnson & Johnson (J&J).

 

Every Friday, VAERS publishes vaccine injury reports received as of a specified date. Reports submitted to VAERS require further investigation before a causal relationship can be confirmed. Historically, VAERS has been shown to report only 1% of actual vaccine adverse events.

U.S. VAERS data from Dec. 14, 2020, to Feb. 4, 2022, for 5- to 11-year-olds show:

The most recent death involves a 7-year-old girl (VAERS I.D. 1975356) from Minnesota who died 11 days after receiving her first dose of Pfizer’s COVID vaccine when she was found unresponsive by her mother. An autopsy is pending.

  • 16 reportsof myocarditis and pericarditis (heart inflammation).
  • 29 reportsof blood clotting disorders.

U.S. VAERS data from Dec. 14, 2020, to Feb. 4, 2022, for 12- to 17-year-olds show:

The most recent deaths involve a 13-year-old male (VAERS I.D. 2042005) from an unidentified state who died from a sudden heart attack seven months after receiving his second dose of Moderna, and a 17-year-old female from an unidentified state (VAERS I.D. 2039111) who died after receiving her first dose of Moderna. Medical information was limited and it is unknown if an autopsy was performed in either case.

  • 68 reportsof anaphylaxis among 12- to 17-year-olds where the reaction was life-threatening, required treatment or resulted in death — with 96% of cases attributed to Pfizer’s vaccine.
  • 629 reportsof myocarditis and pericarditis with 617 cases attributed to Pfizer’s vaccine.
  • 155 reportsof blood clotting disorders, with all cases attributed to Pfizer.

U.S. VAERS data from Dec. 14, 2020, to Feb. 4, 2022, for all age groups combined, show:

 

 

 

Comments

No comments made yet. Be the first to submit a comment
Already Registered? Login Here
Saturday, 23 November 2024

Captcha Image